Sa'ar Yaniv

Stock Analyst

(n/a)
# 4,648
Out of 4,648 analysts
3
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sa'ar Yaniv

Galectin Therapeutics
Oct 19, 2017
Initiates: Buy
Price Target: $8
Current: $2.53
Upside: +216.83%